Exeter, England, United Kingdom
- Liaison between sales and marketing team -Marketing and sales initiative - Sales mentoring - Development of marketing and sales strategy Development of Power BI ( business insights) - Maintenance of financial and medical information compliant with SOPs and regulation - Stakeholder management
Organised, budgeted, and operationally managed regulatory-approved Data Safety Monitoring Board (DSMB/DSMB) meetings, ensuring alignment with GCP, SOPs, and IRB/IRB requirements Managed cross-functional clinical, safety, and biostatistics teams to deliver: Statistical programming, safety case processing, data quality checks, TLFs, and post-meeting outputs Led DSMB-mandated projects supporting Phase III clinical trial regulatory approval, including: Data cleaning, statistical analysis, safety tables, listings, figures, and structured safety reporting Developed and validated statistical safety reports and safety TLF packages for DSMB/IRB submission Chaired and presented at Data Safety Monitoring meetings, communicating safety outcomes to clinical and regulatory stakeholders Forecasted, budgeted, and tracked project financials and clinical safety meeting costs using Power BI and Excel Defined and managed project timelines and dependencies in MS Project and MS Office (Excel, Word, PowerPoint, Teams, Outlook) Produced meeting minutes and formal documentation, including high-accuracy DSMB meeting minutes and audit-ready records Managed and uploaded Trial Master File (TMF) deliverables and ensured compliant archiving Oversaw upload, QC, and maintenance of the Trial Master File (TMF) Maintained TMF accuracy, completeness, version control, and audit-readiness Ensured TMF filing, indexing, and QC met regulatory and inspection standards Managed 20+ concurrent clinical development projects, demonstrating high-precision planning, risk mitigation, and rapid problem resolution Maintained operational accuracy while delivering across multiple therapeutic areas and device/biologic programmes, including: Biologics & dermatology Small cell lung cancer, PD-L1 immuno-oncology Neuro-psychiatry Investigational haemostatic medical device (device safety oversight)
Delivered territory sales growth in the ICS/LABA inhaler market, reversing sales loss from a 40% decline to stabilisation and sustained mild growth across Devon & Somerset Achieved 100% of annual sales target for 2020, securing performance expectations during a highly competitive market year Built and mapped influence across Primary Care Networks (PCNs/PCNs), engaging clinical and pharmacy leadership to drive pathway change Secured endorsement from respiratory consultants and secondary care KOLs to support regional education and system-level adoption Led multi-stakeholder account strategy resulting in NHS guideline change within PCNs, informed by: Clinical director engagement Parallel PCN pharmacy alignment Health-economic budget impact modelling linked to patient outcomes Owned and delivered the Marketing Touchpoint Lead role, translating field intelligence into strategic direction by: Identifying barriers and opportunities within clinical pathways Aligning product positioning with CCG/ICB and NHS PCN priorities Optimising detail aids and marketing assets based on KOL and payer insight Developed and executed territory and regional account plans across South West, and Wiltshire territories mapping relationships and key NHS documents Succeeded in Digital and hybrid role.
Contracted to Logixx and Eli Lilly
Planning and teaching lessons.
Planning and delivering lessons. Managing support staff and appropriate interventions.